These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9047321)
1. Catalytic characteristics of CYP3A4: requirement for a phenolic function in ortho hydroxylation of estradiol and mono-O-demethylated methoxychlor. Stresser DM; Kupfer D Biochemistry; 1997 Feb; 36(8):2203-10. PubMed ID: 9047321 [TBL] [Abstract][Full Text] [Related]
2. Prosubstrates of CYP3A4, the major human hepatic cytochrome P450: transformation into substrates by other P450 isoforms. Stresser DM; Kupfer D Biochem Pharmacol; 1998 Jun; 55(11):1861-71. PubMed ID: 9714305 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of the endocrine disruptor pesticide-methoxychlor by human P450s: pathways involving a novel catechol metabolite. Hu Y; Kupfer D Drug Metab Dispos; 2002 Sep; 30(9):1035-42. PubMed ID: 12167570 [TBL] [Abstract][Full Text] [Related]
4. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation. Butler AM; Murray M J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313 [TBL] [Abstract][Full Text] [Related]
5. Enantioselective metabolism of the endocrine disruptor pesticide methoxychlor by human cytochromes P450 (P450s): major differences in selective enantiomer formation by various P450 isoforms. Hu Y; Kupfer D Drug Metab Dispos; 2002 Dec; 30(12):1329-36. PubMed ID: 12433799 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the major human hepatic cytochrome P450 involved in 4-hydroxylation and N-dechloroethylation of trofosfamide. May-Manke A; Kroemer H; Hempel G; Bohnenstengel F; Hohenlöchter B; Blaschke G; Boos J Cancer Chemother Pharmacol; 1999; 44(4):327-34. PubMed ID: 10447581 [TBL] [Abstract][Full Text] [Related]
7. Identification of CYP3A4 as the enzyme involved in the mono-N-dealkylation of disopyramide enantiomers in humans. Echizen H; Tanizaki M; Tatsuno J; Chiba K; Berwick T; Tani M; Gonzalez FJ; Ishizaki T Drug Metab Dispos; 2000 Aug; 28(8):937-44. PubMed ID: 10901704 [TBL] [Abstract][Full Text] [Related]
8. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450. Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357 [TBL] [Abstract][Full Text] [Related]
9. CYP3A4 is a major isoform responsible for oxidation of 7-hydroxy-Delta(8)-tetrahydrocannabinol to 7-oxo-delta(8)-tetrahydrocannabinol in human liver microsomes. Matsunaga T; Kishi N; Higuchi S; Watanabe K; Ohshima T; Yamamoto I Drug Metab Dispos; 2000 Nov; 28(11):1291-6. PubMed ID: 11038155 [TBL] [Abstract][Full Text] [Related]
10. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Badawi AF; Cavalieri EL; Rogan EG Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Lee AJ; Cai MX; Thomas PE; Conney AH; Zhu BT Endocrinology; 2003 Aug; 144(8):3382-98. PubMed ID: 12865317 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of carteolol by cDNA-expressed human cytochrome P450. Kudo S; Uchida M; Odomi M Eur J Clin Pharmacol; 1997; 52(6):479-85. PubMed ID: 9342584 [TBL] [Abstract][Full Text] [Related]
13. Reconstitution of recombinant cytochrome P450 2C10(2C9) and comparison with cytochrome P450 3A4 and other forms: effects of cytochrome P450-P450 and cytochrome P450-b5 interactions. Yamazaki H; Gillam EM; Dong MS; Johnson WW; Guengerich FP; Shimada T Arch Biochem Biophys; 1997 Jun; 342(2):329-37. PubMed ID: 9186495 [TBL] [Abstract][Full Text] [Related]
14. Mechanism-based inactivation of cytochrome P-450-3A4 by mifepristone (RU486). He K; Woolf TF; Hollenberg PF J Pharmacol Exp Ther; 1999 Feb; 288(2):791-7. PubMed ID: 9918590 [TBL] [Abstract][Full Text] [Related]
15. Human liver microsomal diazepam metabolism using cDNA-expressed cytochrome P450s: role of CYP2B6, 2C19 and the 3A subfamily. Ono S; Hatanaka T; Miyazawa S; Tsutsui M; Aoyama T; Gonzalez FJ; Satoh T Xenobiotica; 1996 Nov; 26(11):1155-66. PubMed ID: 8948091 [TBL] [Abstract][Full Text] [Related]
16. O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4. Relling MV; Nemec J; Schuetz EG; Schuetz JD; Gonzalez FJ; Korzekwa KR Mol Pharmacol; 1994 Feb; 45(2):352-8. PubMed ID: 8114683 [TBL] [Abstract][Full Text] [Related]
17. Cytochrome P-450 3A and 2D6 catalyze ortho hydroxylation of 4-hydroxytamoxifen and 3-hydroxytamoxifen (droloxifene) yielding tamoxifen catechol: involvement of catechols in covalent binding to hepatic proteins. Dehal SS; Kupfer D Drug Metab Dispos; 1999 Jun; 27(6):681-8. PubMed ID: 10348797 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the contribution of cytochrome P450 3A4 to human liver microsomal bupropion hydroxylation. Faucette SR; Hawke RL; Shord SS; Lecluyse EL; Lindley CM Drug Metab Dispos; 2001 Aug; 29(8):1123-9. PubMed ID: 11454731 [TBL] [Abstract][Full Text] [Related]
19. Studies on the interactions between drugs and estrogen: analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 with human NADPH-cytochrome P450 reductase. Satoh T; Fujita KI; Munakata H; Itoh S; Nakamura K; Kamataki T; Itoh S; Yoshizawa I Anal Biochem; 2000 Nov; 286(2):179-86. PubMed ID: 11067738 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the substrate specificities of human liver cytochrome P450s 2C9 and 2C18: application to the design of a specific substrate of CYP 2C18. Minoletti C; Dijols S; Dansette PM; Mansuy D Biochemistry; 1999 Jun; 38(24):7828-36. PubMed ID: 10387023 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]